As of 2024-10-03, the Relative Valuation of Theravance Biopharma Inc (TBPH) is (6.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.21 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -177.9%.
The range of the Relative Valuation is (6.00) - (7.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.1x - 7.6x | 6.5x |
| Forward P/E multiples | 6.4x - 8.5x | 7.2x |
| Fair Price | (6.00) - (7.14) | (6.40) |
| Upside | -173.1% - -186.9% | -177.9% |
| Date | P/E |
| 2024-10-03 | -8.67 |
| 2024-10-02 | -8.79 |
| 2024-10-01 | -8.79 |
| 2024-09-30 | -8.63 |
| 2024-09-27 | -8.67 |
| 2024-09-26 | -8.63 |
| 2024-09-25 | -8.52 |
| 2024-09-24 | -8.58 |
| 2024-09-23 | -8.50 |
| 2024-09-20 | -8.57 |
| 2024-09-19 | -8.79 |
| 2024-09-18 | -8.85 |
| 2024-09-17 | -8.82 |
| 2024-09-16 | -8.69 |
| 2024-09-13 | -8.71 |
| 2024-09-12 | -8.68 |
| 2024-09-11 | -8.67 |
| 2024-09-10 | -8.70 |
| 2024-09-09 | -8.56 |
| 2024-09-06 | -8.57 |
| 2024-09-05 | -8.75 |
| 2024-09-04 | -8.61 |
| 2024-09-03 | -8.56 |
| 2024-08-30 | -8.83 |
| 2024-08-29 | -8.79 |
| 2024-08-28 | -8.73 |
| 2024-08-27 | -8.97 |
| 2024-08-26 | -8.71 |
| 2024-08-23 | -8.66 |
| 2024-08-22 | -8.57 |
| 2024-08-21 | -8.61 |
| 2024-08-20 | -8.80 |
| 2024-08-19 | -8.97 |
| 2024-08-16 | -8.71 |
| 2024-08-15 | -8.83 |
| 2024-08-14 | -8.76 |
| 2024-08-13 | -8.86 |
| 2024-08-12 | -8.82 |
| 2024-08-09 | -8.20 |
| 2024-08-08 | -8.22 |
| 2024-08-07 | -8.38 |
| 2024-08-06 | -8.38 |
| 2024-08-05 | -10.27 |
| 2024-08-02 | -10.32 |
| 2024-08-01 | -10.74 |
| 2024-07-31 | -10.82 |
| 2024-07-30 | -10.77 |
| 2024-07-29 | -10.82 |
| 2024-07-26 | -10.97 |
| 2024-07-25 | -10.93 |